Inside the Forecast (July 21, 2026)

🧠 While the claim that cannabis effects change dramatically with age contains a kernel of clinical truth—older adults do experience altered pharmacokinetics due to reduced hepatic metabolism, changes in body composition, and polypharmacy interactions—the sensationalized framing and association with inflammatory food warnings suggests this content prioritizes engagement over nuance. The reality is more measured: age-related pharmacodynamic shifts are real and clinically relevant, but individual variation, comorbidities, medication interactions, and product composition matter far more than age alone in predicting cannabis response. Healthcare providers should recognize that patients increasingly encounter such claims on social media and may arrive in clinic with misconceptions about age-specific cannabis safety or efficacy. Rather than dismissing patient interest, clinicians can use these conversations as opportunities to discuss evidence-based risks and benefits specific to each patient’s medical profile, particularly regarding cognitive function, fall risk, and drug interactions in older populations. Developing a comfortable